FSE Image Upgrade Kit, Catalog # 92019C This kit is used to install and/or upgrade software us...

FDA Device Recall #Z-0032-2014 — Class III — August 20, 2013

Recall Summary

Recall Number Z-0032-2014
Classification Class III — Low risk
Date Initiated August 20, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bio-Rad Laboratories
Location Redmond, WA
Product Type Devices
Quantity 23 kits

Product Description

FSE Image Upgrade Kit, Catalog # 92019C This kit is used to install and/or upgrade software used with the EVOLIS Microplate System.

Reason for Recall

The FSE Image Upgrade kit (part 92019C) is recalled due to issue related to the export of data from the EVOLIS analyzer to Laboratory Information Systems (LIS) when using the MONOLISA Anti-HBs EIA Quantitative Determination in EVOLIS APF version 6.0.

Distribution Pattern

US Distribution including the states of FL, IA, ME, MO, MS, NE, NY, TN, TX, and WA

Lot / Code Information

Lot 122822

Other Recalls from Bio-Rad Laboratories

Recall # Classification Product Date
Z-1358-2024 Class II Bio-Rad, REF: 12005660, QXDx BCR-ABL %IS Kit Feb 15, 2024
Z-2398-2012 Class II The Bio-Rad MONOLISA Anti-HBs EIA is for In Vit... Jul 27, 2012

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.